Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > 2015

Publikationen 2015


Aboul-Naga SH, Dithmer M, Chitadze G, Kabelitz D, Lucius R, Roider J, Klettner A. Intracellular pathways following uptake of bevacizumab in RPE cells. Exp Eye Res, 131:29-41, 2015

Bhat J, Oberg HH, Kabelitz D. Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors. Cell Immunol, 296:50-6, 2015

Chandrasekaran V, Kalyan S, Biel V, Lettau M, Nerdal PT, Oberg HH, Wesch D, Lindhorst TK, Kabelitz D. Novel synthesis of fluorochrome-coupled zoledronate with preserved functional activity on gamma/delta T cells and tumor cells†. MedChemCommun 6: 919-925, 2015

Ebsen H, Lettau M, Kabelitz D, Janssen O. Subcelluar localization and activation of ADAM proteases in the context of FasL sheding in T lymphocytes. Mol Immunol 65: 416-428, 2015

Hüttl S, Kläsener K, Schweizer M, Schneppenheim J, Oberg HH, Kabelitz D, Reth M, Saftig P, Schröder B. Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells. J Immunol 195: 1548-1563, 2015

Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell GM, Alp G, Schewe D, Hübner S, Tiwari S, Kownatzki D, Boretius S, Adam D, Jonat W, Becker T, Glüer CC, Zöller M, Kalthoff H, Schem C, Trauzold A. TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model. Oncotarget, 6:9502-16, 2015

Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ, 22:58-73, 2015

Görögh T, Quabius ES, Meyer P, Hoffmann M. Characterisation of seven newly established head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol, 272:1251-1258, 2015

Gonnermann D, Oberg HH, Kellner C, Peipp M, Sebens, S, Kabelitz D, Wesch D. Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against T cell cytotoxicity. Oncoimmunology, 4:e988460, 2015

Kalyan S, Wang J, Quabius ES, Huck J, Wiltfang J, Baines JF, Kabelitz D. Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. J Transl Med, 13:212, 2015

Kabelitz D, Déchanet-Merville J. Recent advances in gamma/delta T cell biology: new ligands, new functions, and new translational perspectives. Front Immunol 6: 371, 2015

Kalyan S, He W, Kabelitz D. The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood gd T cells for the treatment of bone cancer metastasis. In: Bone Cancer: Primary Bone Cancer and Bone Metastases. 2nd edition, Heymann D (edt.), pp. 629-636, Elsevier/Academic Press, 2015

Kling C, Kabelitz D. Congenital HCMV and assisted reproduction: Why not use the chance for primary screening? Arch Gynecol Obstet, 291:1205-1211, 2015

Kling C, Kabelitz D. HCMV seroprevalence in couples under infertility treatment. Arch Gynecol Obstet, 292:439-43, 2015

Krossa S, Schmitt AD, Hattermann K, Fritsch J, Scheidig AJ, Mehdorn HM, Held-Feindt J. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1. Oncotarget. 2015 Apr 18. [Epub ahead of print]

Lettau M, Kabelitz D, Janssen O. Lysosome-related effector vesicles in T lymphocytes NK cells. Scand J Immunol 82: 235-243, 2015 

Lettau M, Kabelitz D, Janssen O. SDF1-induced interaction of the adapter proteins Nck and HS1 facilitates actin polymerization and migration in T cells. Eur J Immunol, 45:551-61, 2015

Schüler S, Wolters S, Pitann, S, Kabelitz D, Lamprecht P. Increased co-expression of the natural killer cell receptor NKG2D and further natural killer receptors on CD4+ T cells in granulomatosis with polyangiitis. Clin Exp Rheumatol 33 (2 suppl. 89): 183-184, 2015 

Wang J, Kalyan S, Steck N, Turner LM, Harr B, Künzel S, Oberg HH, Häsler R, Franke A, Grassl GA, Kabelitz D, Baines J. Analysis of the intestinal microbiota of hybrid house mice reveals evolutionary divergence in a vertebrate hologenome. Nat Commun 6: 6440, 2015

Oberg HH, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, Kabelitz D, Wesch D. T cell activation by bispecific antibodies. Cell Immunol, 296:41-49, 2015

Philipp S, Sosna J, Plenge J, Kalthoff H, Adam D. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis. Cell Commun Signal, 13:25, 2015

Quabius ES, Görögh T, Fischer GS, Hoffmann AS, Gebhard M, Evert M, Beule A, Maune S, Knecht R, Ovári A, Durisin M, Hoppe F, Röcken C, Hedderich J, Ambrosch P, Hoffmann M. The antileukoprotease secretory leucocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma. Cancer Lett, 357:339-345, 2015

Shima K, Klinger M, Schütze S, Szasak M, Solbach W, Reiling N, Rupp J. The role of ER-related BiP/GRP78 in IFN- induced persistent Chlamydia pneumoniae infection. Cell Microbiol, 17:923-934, 2015

Zhao Y, Lützen U, Fritsch J, Zuhayra M, Schütze S, Steckelings UM, Recarti C, Namsoleck P, Unger T, Culman J. Activation of intracellular angiotensin AT2 receptors induces rapid cell death in human uterine leiomyosarcoma cells. Clin Sci (Lond), 128:567-78, 2015